You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Micro-Supercapacitor for Integration with MEMS Energy Harvesting and CMOS ICs

    SBC: CFD RESEARCH CORP            Topic: DMEA21A001

    percapacitors provide energy densities comparable to thin film batteries, high power densities, ultrafast recharge, and long cycle lives for applications requiring high duty cycle and pulse power output.  Micro-supercapacitors (MSC) are the most promising energy storage technology for integration with energy harvesting, via micro-electro-mechanical systems (MEMS), and microelectronics integrated ...

    STTR Phase I 2021 Department of DefenseDefense Microelectronics Activity
  2. STTR Phase I: Advancing Health Equity using Interactive Condition Assessment and Monitoring

    SBC: LITERASEED, LLC            Topic: DH

    The broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to build a condition assessment and monitoring platform that leverages artificial intelligence (AI) for intelligent decision support to expedite diagnosis and facilitate personalized therapy solutions. Currently, patient history data is obtained verbally, and poor health communication bet ...

    STTR Phase I 2021 National Science Foundation
  3. STTR Phase I: A kinetic and conformation based platform for targeting G-protein coupled receptors

    SBC: Seven Biosciences, Inc.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable the discovery of new therapeutics targeting G protein-coupled receptors (GCPRs). GPCRs are expressed in nearly every organ system, are accessible due to their location on the membrane and potential to elicit almost every signaling pathway. Drugs targeting GPCRs make up 35% of all ...

    STTR Phase I 2021 National Science Foundation
  4. STTR Phase I: A Pair of Linked Cartographic Maps of our Brain Derived from Clinical Glaucoma Data

    SBC: Gautam Thor            Topic: DH

    The broader impact commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve the accessibility of eye health care. Glaucoma is a major cause of irreversible blindness but can be addressed with early detection, and the prevalence increases with age. However, existing tests can be tiring and difficult and require specialized equipment. This project will adv ...

    STTR Phase I 2021 National Science Foundation
  5. STTR Phase I: A system for collection, transportation and accurate analysis of RNA virus specimens

    SBC: KEPLER DIAGNOSTICS, INC.            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to support a testing device for collection, transportation and diagnosis of certain viral infections, such as hepatitis C virus (HCV), human immunodeficiency virus (HIV) and measles. Recent viral outbreaks of measles, Ebola, Zika, SARS-CoV, and the COVID-19 pandemic have illustrated the nee ...

    STTR Phase I 2021 National Science Foundation
  6. STTR Phase I: Carbon Sequestration & Waste Management for College Campuses & Larger Facilities

    SBC: CARIBOU BIOFUELS, INC.            Topic: ET

    The broader impact/commercial potential of this Small Business Technology Transfer Research Phase I project is to use waste to produce clean, green energy. The proposed technology diverts waste material from landfills while sequestering carbon and can be used in many other industries such as food waste, forestry biomass and disaster relief. For example, wildfires are becoming an annual threat that ...

    STTR Phase I 2021 National Science Foundation
  7. STTR Phase I: Discovery and Development of Macrocyclic Peptide Inhibitors of SARS-COV-2 Spike Protein for the Treatment of COVID-19

    SBC: PHENOTARGET BIOSCIENCES, INC.            Topic: PT

    The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project lies in the discovery and development of first-in-class therapeutics as an anti-viral treatment of COVID-19 viral infection. Within the proposed studies, cyclic peptide-based novel, effective anti-viral drug candidates will be identified. Compared to small molecule-based drugs, peptides will ...

    STTR Phase I 2021 National Science Foundation
  8. STTR Phase I: Feasibility Study of Chip-Scale Iodine Vapor Cell Fabrication

    SBC: VAPOR CELL TECHNOLOGIES LLC            Topic: IH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve measurement science. Currently, special low-pressure chambers known as "vapor cells" are made by hand in a select number of precision glassblowing shops and suffer from poor dimensional reproducibility, low production capacity, irregular sizes, and variable vapor composition lead ...

    STTR Phase I 2021 National Science Foundation
  9. STTR Phase I: Haptics in Telerobotics for Improved Remote Dexterity

    SBC: TANGIBLE RESEARCH INC.            Topic: R

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to advance haptics - electromechanical systems that operate through the sense of touch. This technology may improve the performance of telemanipulation systems, making the operation similar to that of bare hands, and advance a new generation of robotic tools allowing humans to remotely feel ...

    STTR Phase I 2021 National Science Foundation
  10. STTR Phase I: Harnessing the power of introns for safe and effective therapeutics and genomic screening

    SBC: TARTAN LLC            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be the development of a safe and effective treatment for a devastating form of pediatric epilepsy called Dravet syndrome. Dravet syndrome is an inherited disease that is caused by mutations in an ion channel called SCN1A. Gene therapy is an approach that involves replacement of mutated DN ...

    STTR Phase I 2021 National Science Foundation
US Flag An Official Website of the United States Government